/ /


LaparoVue Visibility SystemJames Greenberg, MD, reviews the LaparoVue Visibility System, a single-use, disposable system designed to eliminate fogging while cleaning laparoscopes and trocars during a procedure.
Maternal Mortality Postpartum Hemorrhage ResourcesA collection of standards, guidelines, tools and articles for the OB managing postpartum hemorrhage.
Rating scale criteria for sexual desire differ between clinician, patientIn large part, clinicians and patients do not see eye to eye when it comes to what they consider important criteria for a rating scale assessing female sexual desire, according to a literature review
Sex hormones only part of the equation in modulating HSDDAccording to a literature review, apart from the essential role that sex hormones play in modulating hypoactive sexual desire disorder (HSDD) through therapeutic interventions, a comprehensive understanding of the biologic mechanisms underlying the disorder is imperative.
Is waist-to-hip ratio a better predictor of MI than BMI?According to research, the size of a woman’s hips and waist may be the best indicators of her risk of a heart attack. Plus: Adverse risks of pregnancy over 40. Also: Active surveillance of CIN2 is a viable treatment, according to a study.
Study: No association between prenatal ultrasound duration and autismContemporary OB/GYN Editorial Board member Joshua A. Copel, MD, provides expert perspective on a controversial retrospective study that looked at whether exposure to prenatal ultrasound is associated with diagnosis of autism. Plus: Can a placenta-on-a-chip be used to analyze placental perfusion? Also: More mothers receiving antihypertensives for preeclampsia and fewer are having strokes.
USPSTF: Ovarian cancer screening not recommended for low-risk womenIn a new statement, the US Preventive Services Task Force (USPSTF) is recommending against ovarian cancer screening for women who have no symptoms and no hereditary cancer syndromes. Plus: Breast MRI screening results in higher biopsy rates, according to a study.
Vulvar pruritus in postmenopausal womanA 62-year-old woman presents for her annual gynecologic exam, stating that she has had a 4-month history of worsening vulvar pruritus. Can you make the correct diagnosis and treatment plan?
Lower-Dose Estradiol Vaginal Cream Effectively Relieves Postmenopausal DyspareuniaA lower-dose estradiol vaginal cream than is currently available in the United States was an effective and well-tolerated treatment for dyspareunia in postmenopausal women, according to a recent phase 3, randomized, multicenter, double-blind, placebo-controlled trial.
Cervical Cancer Survivors Have High Scores for Sexual DistressHigher levels of distress were linked to increased vaginal sexual symptoms, worry about dyspareunia, dissatisfaction with a relationship, and concerns about body image in a study looking at sexual well-being among cervical cancer survivors.